{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:43:08Z","timestamp":1784698988199,"version":"3.55.0"},"reference-count":174,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1555,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1365-2133.2011.10217.x","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T05:41:31Z","timestamp":1294724491000},"page":"5-17","source":"Crossref","is-referenced-by-count":87,"title":["Targeted treatment of pruritus: a look into the future"],"prefix":"10.1093","volume":"165","author":[{"given":"H.L.","family":"Tey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,5,30]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2340\/00015555-0662","article-title":"Epidemiology of itch: adding to the burden of skin morbidity","volume":"89","author":"Weisshaar","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1038\/sj.jid.5700818","article-title":"The pruritus receptor unit: a target for novel therapies","volume":"127","author":"Yosipovitch","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/00015555-0305","article-title":"Clinical classification of itch: a position paper of the International Forum for the Study of Itch","volume":"87","author":"St\u00e4nder","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2222.2004.01876.x","article-title":"Pruritus-associated response mediated by cutaneous histamine H3 receptors","volume":"34","author":"Sugimoto","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2133.2003.05341.x","article-title":"Involvement of histamine H3 receptors in scratching behaviour in mast cell-deficient mice","volume":"149","author":"Hossen","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.bjp.0705754","article-title":"Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice","volume":"142","author":"Bell","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"36781","DOI":"10.1074\/jbc.M006480200","article-title":"Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes","volume":"275","author":"Oda","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2008.12.1110","article-title":"The histamine H4 receptor is functionally expressed on T(H)2 cells","volume":"123","author":"Gutzmer","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2007.03.024","article-title":"Histamine downregulates monocyte CCL2 production through the histamine H4 receptor","volume":"120","author":"Dijkstra","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.jid.5701250","article-title":"Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor","volume":"128","author":"Dijkstra","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaci.2006.08.034","article-title":"Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus","volume":"119","author":"Dunford","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1398-9995.2008.01720.x","article-title":"Histamine H4 receptors modulate dendritic cell migration through skin-immunomodulatory role of histamine","volume":"63","author":"B\u00e4umer","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0625.2008.00762.x","article-title":"Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation","volume":"18","author":"Rossbach","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2131\/jts.34.427","article-title":"Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist","volume":"34","author":"Yamaura","year":"2009","journal-title":"J Toxicol Sci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-2999(01)01588-6","article-title":"Antipruritic activity of the kappa-opioid receptor agonist, TRK-820","volume":"435","author":"Togashi","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/jid.2009.358","article-title":"The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation","volume":"130","author":"Cowden","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB18|cit18","first-page":"628","article-title":"A new generation of anti-histamines: histamine H4 receptor antagonists on their way to the clinic","volume":"12","author":"Engelhardt","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1152\/jn.90482.2008","article-title":"Separate peripheral pathways for pruritus in man","volume":"100","author":"Namer","year":"2008","journal-title":"J Neurophysiol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1523\/JNEUROSCI.0716-08.2008","article-title":"Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors","volume":"28","author":"Reddy","year":"2008","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1523\/JNEUROSCI.1760-08.2008","article-title":"A role for polymodal C-fiber afferents in nonhistaminergic itch","volume":"28","author":"Johanek","year":"2008","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"10007","DOI":"10.1523\/JNEUROSCI.2862-07.2007","article-title":"The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons","volume":"27","author":"Davidson","year":"2007","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1152\/jn.00463.2009","article-title":"Excitation of mouse superficial dorsal horn neurons by histamine and\/or PAR-2 agonist: potential role in itch","volume":"102","author":"Akiyama","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1152\/jn.91268.2008","article-title":"Pruritic and nociceptive sensations and dysesthesias from a spicule of cowhage","volume":"101","author":"LaMotte","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","article-title":"Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin","volume":"23","author":"Steinhoff","year":"2003","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1254\/jphs.08332FP","article-title":"Involvement of tryptase and proteinase-activated receptor-2 in spontaneous itch-associated response in mice with atopy-like dermatitis","volume":"109","author":"Tsujii","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2005.11.021","article-title":"Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice","volume":"530","author":"Ui","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/jid.2009.430","article-title":"Cathepsin S elicits itch and signals via protease-activated receptors","volume":"130","author":"Reddy","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/sj.jid.5700351","article-title":"Serine protease signaling of epidermal permeability barrier homeostasis","volume":"126","author":"Hachem","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2006.02.047","article-title":"Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma","volume":"118","author":"Chen","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.bjp.0705121","article-title":"A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium","volume":"138","author":"Sendo","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2340\/00015555-0869","article-title":"Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate","volume":"90","author":"Takahagi","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/AAC.01540-08","article-title":"Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes","volume":"53","author":"Ishikawa","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1073\/pnas.022460899","article-title":"Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides","volume":"99","author":"Covic","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/art.22423","article-title":"Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist","volume":"56","author":"Kelso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pain.2010.07.024","article-title":"Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch","volume":"151","author":"Akiyama","year":"2010","journal-title":"Pain"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj2010189","article-title":"L-trans-Epoxysuccinyl-leucylamido(4-guanidino)-butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L","volume":"201","author":"Barrett","year":"1982","journal-title":"Biochem J"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-0625.2009.00844.x","article-title":"Opioids and the skin - where do we stand?","volume":"18","author":"Bigliardi","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2009.08.052","article-title":"Antipruritic treatment with systemic \u03bc-opioid receptor antagonists: a review","volume":"63","author":"Phan","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-6147(98)01169-9","article-title":"mu-Opposing actions of the kappa-opioid receptor","volume":"19","author":"Pan","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2003.08.007","article-title":"Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system","volume":"477","author":"Umeuchi","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB43|cit43","first-page":"1125","article-title":"Effect of oral naltrexane on pruritus in cholestatic patients","volume":"12","author":"Mansour-Ghanaei","year":"2006","journal-title":"Wold J Gastroenterol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0190-9622(89)80353-6","article-title":"Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis","volume":"21","author":"Monroe","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1034\/j.1600-0625.2002.110508.x","article-title":"Efficacy of naltrexone on acetylcholine-induced allokinesis in atopic eczema","volume":"11","author":"Heyer","year":"2002","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstrom","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB47|cit47","unstructured":"Toray Industries, Inc Phase II Study of TRK-820 Soft Capsules - Intractable Pruritus in Patients with Chronic Liver Disease 2010 http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00638495?term=nalfurafine&rank=2"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1021\/jm00067a004","article-title":"A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines","volume":"36","author":"Naylor","year":"1993","journal-title":"J Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.108.143925","article-title":"Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates","volume":"328","author":"Ko","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","article-title":"Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-controlled study","volume":"25","author":"Kumagai","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB51|cit51","first-page":"178","article-title":"Treatment of epidural morphine induced pruritus with butorphanol","volume":"58","author":"Yokoyama","year":"2009","journal-title":"Masui"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","article-title":"Butorphanol for treatment of intractable pruritus","volume":"54","author":"Dawn","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0376-8716(98)00087-8","article-title":"Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine","volume":"52","author":"Yuan","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1345\/aph.10121","article-title":"Opioid antagonists in the treatment of opioid-induced constipation and pruritus","volume":"35","author":"Friedman","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB55|cit55","unstructured":"Tioga Pharmaceuticals Asimadoline for the Treatment of Subjects with Irritable Bowel Syndrome 2008 http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00454688?term=asimadoline&rank=2"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB56|cit56","unstructured":"Cowan A Inan S Kappa opioid agonists as potential antipruritics Presented at 40th Annual Meeting for the Society for Neuroscience 2010"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2010.08.012","article-title":"SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects","volume":"647","author":"Tsukahara-Ohsumi","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2007.01.007","article-title":"Treatment of pruritus with topically applied opiate receptor antagonist","volume":"56","author":"Bigliardi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2340\/00015555-0480","article-title":"In vitro and in vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus","volume":"88","author":"Lim","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","article-title":"Structure and biological functions of IL-31 and IL-31 receptors","volume":"19","author":"Zhang","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2007.07.065","article-title":"A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema","volume":"120","author":"Schulz","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2133.2009.09311.x","article-title":"New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis","volume":"161","author":"Tanaka","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ejhg.2009.135","article-title":"Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis","volume":"18","author":"Lin","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2008.00766.x","article-title":"Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC\/Nga mice: a model of atopic dermatitis","volume":"18","author":"Grimstad","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.0906-6705.2004.0178.x","article-title":"Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures","volume":"13","author":"Stander","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.0022-202X.2004.23209.x","article-title":"Vanilloid receptor-1 (VR1) is widely expressed on various epithelial and mesenchymal cell types of human skin","volume":"123","author":"Bodo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1006\/bbrc.2001.5299","article-title":"Immunoreactivity of VR1 on epidermal keratinocyte of human skin","volume":"285","author":"Denda","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0140-6736(03)12570-6","article-title":"Itch","volume":"361","author":"Yosipovitch","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-0625.2002.110102.x","article-title":"Pathophysiology of pruritus in atopic dermatitis: an overview","volume":"11","author":"Stander","year":"2002","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1073\/pnas.0905605106","article-title":"TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms","volume":"106","author":"Imamachi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1523\/JNEUROSCI.4643-06.2007","article-title":"TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase","volume":"27","author":"Shim","year":"2007","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"50080","DOI":"10.1074\/jbc.M306619200","article-title":"Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway","volume":"278","author":"Mohapatra","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/35082088","article-title":"Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition","volume":"411","author":"Chuang","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.97.11.6155","article-title":"Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances","volume":"97","author":"Hwang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1517\/14656566.2010.481670","article-title":"Topical capsaicin. The fire of a \u2018hot\u2019 medicine is reignited","volume":"11","author":"Papoiu","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1159\/000188949","article-title":"Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream","volume":"72","author":"Tarng","year":"1996","journal-title":"Nephron"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0190-9622(93)70208-B","article-title":"A double-blind evaluation of topical capsaicin in pruritic psoriasis","volume":"29","author":"Ellis","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0190-9622(94)70022-2","article-title":"Treatment of aquagenic pruritus with topical capsaicin cream","volume":"30","author":"Lotti","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/000155599750011327","article-title":"Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia","volume":"79","author":"Yosipovitch","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB82|cit82","first-page":"702","article-title":"NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain","volume":"10","author":"Noto","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB83|cit83","first-page":"488","article-title":"An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature","volume":"9","author":"Fleischer","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB84|cit84","first-page":"1","article-title":"Pruritus: control of itch in patients undergoing dialysis","volume":"15","author":"Mettang","year":"2010","journal-title":"Skin Therapy Lett"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/tcrm.2006.2.2.213","article-title":"Treatment of pruritic diseases with topical calcineurin inhibitors","volume":"2","author":"Stander","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2133.2010.09757.x","article-title":"Mechanisms of the sensory effects of tacrolimus on the skin","volume":"163","author":"Pereira","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature00882","article-title":"TRPV3 is a calcium-permeable temperature-sensitive cation channel","volume":"418","author":"Xu","year":"2002","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1038\/sj.jid.5700468","article-title":"Association of a mutation in TRPV3 with defective hair growth in rodents","volume":"126","author":"Asakawa","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/jid.2008.245","article-title":"Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice","volume":"129","author":"Yoshioka","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/jid.2008.440","article-title":"A TR(I)P to pruritus research: role of TRPV3 in inflammation and itch","volume":"129","author":"Steinhoff","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1523\/JNEUROSCI.2574-05.2005","article-title":"Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism","volume":"25","author":"Xu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB92|cit92","first-page":"115","volume-title":"Itch: Basic Mechanisms and Therapy","author":"Rukwied","year":"2004"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00011-003-1162-z","article-title":"Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin","volume":"52","author":"Dvorak","year":"2003","journal-title":"Inflamm Res"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020070043","article-title":"Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice","volume":"107","author":"Darmani","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)","volume":"22","author":"Eberlein","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/0264-6021:3580249","article-title":"Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances anti-proliferative effect of anandamide in human breast cancer cells","volume":"358","author":"Di Marzo","year":"2001","journal-title":"Biochem J"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1556\/APhysiol.97.2010.2.1","article-title":"The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons","volume":"97","author":"S\u00e1ntha","year":"2010","journal-title":"Acta Physiol Hung"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.108.150136","article-title":"Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus","volume":"329","author":"Schlosburg","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"13019","DOI":"10.1021\/bi701378g","article-title":"Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity","volume":"46","author":"Ahn","year":"2007","journal-title":"Biochemistry"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2004.12.019","article-title":"Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1","volume":"161","author":"Groneberg","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1523\/JNEUROSCI.14-03-01422.1994","article-title":"Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system","volume":"14","author":"Albers","year":"1994","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1523\/JNEUROSCI.15-03-02081.1995","article-title":"Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons","volume":"15","author":"Verge","year":"1995","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00403-006-0657-1","article-title":"Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study","volume":"298","author":"Dou","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jdermsci.2008.08.011","article-title":"Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis","volume":"53","author":"Yamaguchi","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00403-001-0285-8","article-title":"Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin - an exploration of the cause of neurohyperplasia","volume":"293","author":"Johansson","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB107|cit107","first-page":"769","article-title":"Pruritus and nerve growth factor in psoriasis","volume":"43","author":"Choi","year":"2005","journal-title":"Korean J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s004410000202","article-title":"Increase in NGF content and nerve fiber sprouting in human allergic contact eczema","volume":"302","author":"Kinkelin","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1254\/jphs.FP0050564","article-title":"Effects of anti-nerve growth factor antibody on symptoms in the NC\/Nga mouse, an atopic dermatitis model","volume":"99","author":"Takano","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.2006.07636.x","article-title":"Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC\/Nga mouse atopic dermatitis model","volume":"156","author":"Takano","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pain.2005.02.022","article-title":"Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization","volume":"115","author":"Sevcik","year":"2005","journal-title":"Pain"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.1158\/0008-5472.CAN-05-0826","article-title":"A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone","volume":"65","author":"Halvorson","year":"2005","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pain.2007.06.016","article-title":"Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture","volume":"133","author":"Jimenez-Andrade","year":"2007","journal-title":"Pain"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB114|cit114","first-page":"94","article-title":"Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain","volume":"12","author":"Cattaneo","year":"2010","journal-title":"Curr Opin Mol Ther"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for the treatment of pain from osteoarthritis of the knee","volume":"363","author":"Lane","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB116|cit116","unstructured":"Clinical Trials Tanezumab 2010 http:\/\/www.clinicaltrials.gov\/ct2\/results?term=tanezumab"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1046\/j.1523-1747.2000.00974.x","article-title":"Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis","volume":"114","author":"Grewe","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2133.2007.08149.x","article-title":"Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P","volume":"157","author":"Hon","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2133.1962.tb13518.x","article-title":"Acetylcholine in normal and diseased skin","volume":"74","author":"Scott","year":"1962","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1254\/jjp.88.351","article-title":"Intradermal cholinergic agonists induce itch-associated response via M3 muscarinic acetylcholine receptors in mice","volume":"88","author":"Miyamoto","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1346-8138.1997.tb02305.x","article-title":"Acetylcholine is an inducer of itching in patients with atopic eczema","volume":"24","author":"Heyer","year":"1997","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2340\/0001555575434436","article-title":"Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects","volume":"75","author":"Vogelsang","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2133.2009.09305.x","article-title":"Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin","volume":"161","author":"Gazerani","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pain.2006.10.030","article-title":"Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin","volume":"130","author":"Tugnoli","year":"2007","journal-title":"Pain"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pain.2008.10.005","article-title":"Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin","volume":"141","author":"Gazerani","year":"2009","journal-title":"Pain"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00415-003-0971-x","article-title":"Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin","volume":"250","author":"Kramer","year":"2003","journal-title":"J Neurol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mjd.2002.120455","article-title":"Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study","volume":"46","author":"Heckmann","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/archderm.143.8.980","article-title":"Successful treatment of notalgia paresthetica with botulinum toxin type A","volume":"143","author":"Weinfeld","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/WNF.0b013e3181672225","article-title":"Relief of intractable pruritus after administration of botulinum toxin A (Botox): a case report","volume":"31","author":"Salardini","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2010.09783.x","article-title":"Botulinum toxin type A for neuropathic itch","volume":"163","author":"Wallengren","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/nn.2683","article-title":"Toll-like receptor 7 mediates pruritus","volume":"13","author":"Liu","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature06029","article-title":"A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord","volume":"448","author":"Sun","year":"2007","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.1174868","article-title":"Cellular basis of itch sensation","volume":"325","author":"Sun","year":"2009","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cell.2009.11.034","article-title":"Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus","volume":"139","author":"Liu","year":"2009","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB135|cit135","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cell.2009.12.012","article-title":"Itching for insight","volume":"139","author":"Bandell","year":"2009","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000270385","article-title":"Responses to intradermal injections of substance P in psoriasis patients with pruritus","volume":"23","author":"Amatya","year":"2010","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1523-1747.2000.00142.x","article-title":"Acute effects of substance P and calcitonin gene-related peptide in human skin - a microdialysis study","volume":"115","author":"Weidner","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2174\/0929867043364748","article-title":"Tachykinins and tachykinin receptors: structure and activity relationships","volume":"11","author":"Almeida","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/WNR.0b013e328337310a","article-title":"Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats","volume":"21","author":"Carstens","year":"2010","journal-title":"Neuroreport"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00003495-200464070-00013","article-title":"Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting","volume":"64","author":"Dando","year":"2004","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMc0906670","article-title":"Aprepitant as an antipruritic agent?","volume":"361","author":"Duval","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB142|cit142","first-page":"665","article-title":"Oral aprepitant is highly efficient in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma","volume":"164","author":"Booken","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00520-010-0895-9","article-title":"Aprepitant against pruritus in patients with solid tumours","volume":"18","author":"Vincenzi","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMc1003937","article-title":"Aprepitant for erlotinib-induced pruritus","volume":"363","author":"Vincenzi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","article-title":"Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy","volume":"5","author":"St\u00e4nder","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","article-title":"Lysophosphatidic acid is a potential mediator of cholestatic pruritus","volume":"139","author":"Kremer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neubiorev.2008.12.004","article-title":"Itch and pain","volume":"34","author":"Schmelz","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pain.2007.04.017","article-title":"Chronic itch and chronic pain: analogous mechanisms","volume":"131","author":"Yosipovitch","year":"2007","journal-title":"Pain"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB149|cit149","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/SPC.0b013e3282efc58b","article-title":"Neuroimaging of pain mechanisms","volume":"1","author":"Tracey","year":"2007","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB150|cit150","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1365-2133.2009.09308.x","article-title":"Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis","volume":"161","author":"Ishiuji","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1152\/jn.00460.2009","article-title":"Time course of activity in itch-related brain regions: a combined MEG-fMRI study","volume":"102","author":"Mochizuki","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/jid.2008.3","article-title":"The brain processing of scratching","volume":"128","author":"Yosipovitch","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB153|cit153","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(99)00226-9","article-title":"Modulation of memory processing in the cingulate cortex of mice","volume":"65","author":"Farr","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1364-6613(00)01483-2","article-title":"Cognitive and emotional influences in anterior cingulate cortex","volume":"4","author":"Bush","year":"2000","journal-title":"Trends Cogn Sci"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB155|cit155","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2004.01.045","article-title":"Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study","volume":"50","author":"Hundley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaad.2006.04.025","article-title":"Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma","volume":"55","author":"Demierre","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB157|cit157","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","article-title":"Mirtazapine for pruritus","volume":"25","author":"Davis","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB158|cit158","unstructured":"Clinical Trials ORG 50081 2010 http:\/\/clinicaltrials.gov\/ct2\/results?term=ORG+50081"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB159|cit159","unstructured":"Becker JR Future Treatments for Depression, Anxiety, Sleep Disorders, Psychosis, and ADHD 2009 http:\/\/www.neurotransmitter.net\/newdrugs.html"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB160|cit160","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1517\/14656566.2010.507192","article-title":"A review of SSRIs and SNRIs in neuropathic pain","volume":"11","author":"Lee","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB161|cit161","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.euroneuro.2008.06.002","article-title":"Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents","volume":"18","author":"Brocco","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB162|cit162","unstructured":"GlaxoSmithKline A Combination Therapy in Patients with Social Anxiety Disorder 2008 http:\/\/www.clinicaltrials.gov\/ct2\/results?term=vestipitant&rank=4"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00008877-200302000-00009","article-title":"The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test","volume":"14","author":"Varty","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB164|cit164","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.npp.1301586","article-title":"Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists","volume":"33","author":"Wallace-Boone","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB165|cit165","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0893-133X(02)00313-5","article-title":"The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists","volume":"27","author":"Varty","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB166|cit166","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2005.07.013","article-title":"Lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder","volume":"59","author":"Keller","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB167|cit167","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","article-title":"Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial","volume":"19","author":"Gunal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB168|cit168","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08860220802595476","article-title":"Gabapentin and uremic pruritus in hemodialysis patients","volume":"31","author":"Razeghi","year":"2009","journal-title":"Ren Fail"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB169|cit169","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21370","article-title":"Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial","volume":"44","author":"Bergasa","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB170|cit170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ackd.2005.03.004","article-title":"Potential benefits of complementary medicine modalities in patients with chronic kidney disease","volume":"12","author":"Markell","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB171|cit171","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/00207140208410096","article-title":"The efficacy of hypnosis in the treatment of pruritus in people with HIV\/AIDS: a time-series analysis","volume":"50","author":"Rucklidge","year":"2002","journal-title":"Int J Clin Exp Hypn"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB172|cit172","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archderm.136.3.393","article-title":"Hypnosis in dermatology","volume":"136","author":"Shenefelt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB173|cit173","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1529-8019.2003.01620.x","article-title":"Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind?","volume":"16","author":"Shenefelt","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1365-2133.2011.10217.x-BIB174|cit174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000101940","article-title":"The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis","volume":"144","author":"Chida","year":"2007","journal-title":"Int Arch Allergy Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10217.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T22:44:58Z","timestamp":1712097898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/165\/1\/5\/6644090"}},"subtitle":["Targeted antipruritic treatment"],"short-title":[],"issued":{"date-parts":[[2011,5,30]]},"references-count":174,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10217.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,30]]}}}